Conditions: Postoperative Ecchymosis
Keywords: Rhinoplasty Ecchymosis Edema
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 14
Healthy volunteers: no

Brief summary:
This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a drug used in patients with bleeding disorders. It works by activating molecules in the blood stream called platelets that promote clotting. In the study, participants who are have cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive medication. Photographs taken before and shortly after surgery will be evaluated for the amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not eligible to participate.

Detailed description:

Arms:
arm 1: Arm receiving DDAVP prior to the operation. Drug is administered intravenously at .3mcg per kg, over 30 minutes prior to the operation. arm 2: Patients Will not receive DDAVP prior to Rhinoplasty

Interventions: intervention 1: DDAVP
Intervention descriptions: intervention 1: Patients Receiving DDAVP prior to operation

Protocol document: